Zylox-Tonbridge Medical Technology Balance Sheet Health
Financial Health criteria checks 3/6
Zylox-Tonbridge Medical Technology has a total shareholder equity of CN¥3.0B and total debt of CN¥50.0M, which brings its debt-to-equity ratio to 1.6%. Its total assets and total liabilities are CN¥3.4B and CN¥328.3M respectively.
Key information
1.6%
Debt to equity ratio
CN¥50.00m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥1.51b |
| Equity | CN¥3.05b |
| Total liabilities | CN¥328.32m |
| Total assets | CN¥3.38b |
Recent financial health updates
We're Not Very Worried About Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Rate
Jun 30
We're Not Very Worried About Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Rate
Jan 19Here's Why We're Not Too Worried About Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Situation
Jul 06We're Hopeful That Zylox-Tonbridge Medical Technology (HKG:2190) Will Use Its Cash Wisely
Jan 27Here's Why We're Not At All Concerned With Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Situation
Oct 05Recent updates
Zylox-Tonbridge Medical Technology Co., Ltd.'s (HKG:2190) Shares May Have Run Too Fast Too Soon
Apr 23Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190) Shares Could Be 48% Below Their Intrinsic Value Estimate
Jan 18Does This Valuation Of Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190) Imply Investors Are Overpaying?
Sep 21There's Reason For Concern Over Zylox-Tonbridge Medical Technology Co., Ltd.'s (HKG:2190) Price
Aug 03We're Not Very Worried About Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Rate
Jun 30Is Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190) Trading At A 45% Discount?
Mar 08We're Not Very Worried About Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Rate
Jan 19Here's Why We're Not Too Worried About Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Situation
Jul 06We're Hopeful That Zylox-Tonbridge Medical Technology (HKG:2190) Will Use Its Cash Wisely
Jan 27Here's Why We're Not At All Concerned With Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Situation
Oct 05Financial Position Analysis
Short Term Liabilities: 2190's short term assets (CN¥1.7B) exceed its short term liabilities (CN¥317.8M).
Long Term Liabilities: 2190's short term assets (CN¥1.7B) exceed its long term liabilities (CN¥10.5M).
Debt to Equity History and Analysis
Debt Level: 2190 has more cash than its total debt.
Reducing Debt: Insufficient data to determine if 2190's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if 2190 has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if 2190 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.